abstract |
The present invention relates to a tumor necrosis factor-alpha converting enzyme (TACE) shRNA and a non-viral gene carrier having an effect of preventing or treating an inflammatory disease, wherein the non- To a gene / carrier complex comprising an acetate of poly (oligo-arginine). |